Share buyback conducted. Target is common shares, planned cap at 900,000 shares, total amount up to 2,000,000,000 yen (cap). Actual buyback executed from July 1 to July 31, 2026, via market purchase: 192,500 shares, total 606,175,989 yen. Cumulative as of July 31: 358,300 shares, total 1,093,270,987 yen.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4526","jir_company_name":"Riken Vitamin Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-08-03","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/08\/4526-20260803-01.pdf","jir_short_summary":"Share buyback conducted. Target is common shares, planned cap at 900,000 shares, total amount up to 2,000,000,000 yen (cap). Actual buyback executed from July 1 to July 31, 2026, via market purchase: 192,500 shares, total 606,175,989 yen. Cumulative as of July 31: 358,300 shares, total 1,093,270,987 yen.","jir_summary":"### Overview of the acquisition\nThis is a summary of the share buyback conducted by Riken Vitamin based on the resolution of the Board of Directors on May 13, 2026. The target is common shares, acquisition period is from July 1 to July 31, 2026, and the method was market purchases. In this tranche, within a cap of 3.08%, 192,500 shares were acquired for 606,175,989 yen.\n\n### Cumulative information and outlook\nAs of July 31, 2026, the cumulative total is 358,300 shares, totaling 1,093,270,987 yen. The cap is 900,000 shares and up to 2,000,000,000 yen, and the period is from June 1 to September 30, but this report reflects acquisitions through July 31. The existence and frequency of any further acquisitions are unknown.","jir_financial_highlights":"Total number of shares acquired: 192,500 shares (07\/01\uff5e07\/31 acquisition)\nTotal acquisition amount: 606,175,989 yen (Result within acquisition period)\nAcquisition period: 2026 July 1 to 2026 July 31\nCumulative shares acquired (as of July 31, 2026): 358,300 shares (as of July 31)\nCumulative acquisition amount (as of July 31, 2026): 1,093,270,987 yen (as of July 31)","jir_category":"","jir_hashtags":"#RikenVitamin, #ShareBuyback, #IR","jir_key_figures":"Total shares acquired: 192,500 shares\nTotal acquisition amount: 606,175,989 yen\nCumulative shares acquired (as of July 31, 2026): 358,300 shares\nCumulative acquisition amount (as of July 31, 2026): 1,093,270,987 yen","jir_meta_title":"[Riken Vitamin] Notice of Share Buyback Status | July 31, 2026","jir_meta_description":"Riken Vitamin discloses the status of its share buyback, detailing target shares, total shares acquired, total amount, period, method, and cumulative totals. Further acquisitions are unknown.","jir_og_title":"[Riken Vitamin] Notice of Share Buyback Status | July 31, 2026","jir_og_description":"Riken Vitamin discloses its share buyback. Reports the number of shares acquired, total amount, period, and cumulative totals. Future developments are unknown.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":16690,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"share_buyback","footnotes":""},"sector":[],"importance":[],"class_list":["post-93830","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n